Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Cerilliant
Moodys
McKesson
Merck
Accenture
Deloitte
Citi
Johnson and Johnson

Generated: July 19, 2018

DrugPatentWatch Database Preview

CANTIL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Cantil, and when can generic versions of Cantil launch?

Cantil is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in CANTIL is mepenzolate bromide. There is one drug master file entry for this compound. Additional details are available on the mepenzolate bromide profile page.
Summary for CANTIL
US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: 38
Patent Applications: 1,010
DailyMed Link:CANTIL at DailyMed
Drug patent expirations by year for CANTIL
Synonyms for CANTIL
(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenyl-acetate bromide
(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate
(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate bromide
(1,1-dimethylpiperidin-1-ium-3-yl) 2-hydroxy-2,2-diphenylacetate;bromide
1-Methyl-3-piperidyl benzilate methyl bromide
1-Methyl-3-piperidyl benzilate methylbromide
1988AC
2-(1,1-dimethylpiperidin-1-ium-3-yl)oxy-2-oxo-1,1-diphenylethanolate
2-[(1,1-dimethylpiperidinium-3-yl)oxy]-2-oxo-1,1-diphenylethanolate
25990-43-6 (Parent)
3-((Hydroxydiphenylacetyl)oxy)-1,1-dimethylpiperidinium bromide
3-(2-Hydroxy-2,2-diphenylacetoxy)-1,1-dimethylpiperidin-1-ium bromide
3-[(Hydroxy-diphenylacetyl)oxy]-1,1-dimethylpiperidinium Bromide
3-{[hydroxy(diphenyl)acetyl]oxy}-1,1-dimethylpiperidinium bromide
3-Hydroxy-1,1-dimethylpiperidinium bromide benzilate
76-90-4
88215-34-3
AC-15989
AC1L1MKX
AC1Q1R9F
AK116470
AKOS015962135
AN-6437
API0000641
AX8137418
Benzilic acid, 1-methyl-3-piperidyl ester methobromide
Benzilic acid, ester with 3-hydroxy-1,1-dimethylpiperidinium bromide
Benzilic acid,1-dimethylpiperidinium bromide
Bromure de mepenzolate
Bromure de mepenzolate [INN-French]
Bromuro de mepenzolato
Bromuro de mepenzolato [INN-Spanish]
C21H26BrNO3
C21H26NO3
Cantil (TN)
Cantilaque
Cantilon
Cantril
CAS-76-90-4
CCG-40131
CHEBI:6753
CHEMBL1724
Colibantil
Colopiril
Colum
CPD000058832
CS-3578
D00720
D0FV3V
Delevil
DSSTox_CID_3252
DSSTox_GSID_23252
DSSTox_RID_76941
DTXSID4023252
Eftoron
EINECS 200-992-7
FT-0671006
Gastropidil
Glycophenylate
HE017053
HE329583
HMS1570C07
HMS1920L05
HMS2091B18
HMS2097C07
HMS2231P11
HMS3259O19
HMS3369A20
HMS501P18
HY-17585
JB 340
KB-232690
KS-0000119J
LS-116643
Mepenzolate (Bromide)
MEPENZOLATE BROMIDE
Mepenzolate bromide (JP15/INN)
Mepenzolate bromide (JP17/INN)
Mepenzolate bromide [INN:BAN:JAN]
Mepenzolate Methylbromide
Mepenzolati bromidum
Mepenzolati bromidum [INN-Latin]
mepenzolic acid, bromine salt
Mepenzolone Bromide
MLS001076678
MLS002222165
MolPort-003-666-226
N-Methyl-3-piperidyl benzilate methobromide
N-Methyl-3-piperidyl benzilate methyl bromide
N-methyl-3-piperidylbenzilate methyl bromide
N-Methyl-3-piperidyldiphenylglycolate methobromide
NC00518
NCGC00016314-01
NCGC00094716-01
NCGC00094716-02
NCGC00178896-05
NSC 4358
NSC-4358
NSC-757099
NSC4358
NSC757099
Pharmakon1600-01500383
Piperidinium, 3-((hydroxydiphenylacetyl)oxy)-1,1-dimethyl-, bromide
Piperidinium, 3-((hydroxydiphenylacetyl)oxy)-1,1-dimethyl-(VAN)
Piperidinium, 3-[(hydroxydiphenylacetyl)oxy]-1,1-dimethyl-, bromide
Piperidinium, 3-hydroxy-1,1-dimethyl-, bromide, benzilate
Piperidinium,1-dimethyl-, bromide
Piperidinium,1-dimethyl-, bromide, benzilate
Prestwick_100
SAM002554910
SCHEMBL99030
SMR000058832
SPECTRUM1500383
SR-01000765452
SR-01000765452-2
Tox21_110367
Tox21_110367_1
Tralanta
Trancolon
Trokonil
WLN: T6KTJ A1 A1 COVXQR&R &E

US Patents and Regulatory Information for CANTIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us CANTIL mepenzolate bromide SOLUTION;ORAL 010679-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us CANTIL mepenzolate bromide TABLET;ORAL 010679-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Fuji
Federal Trade Commission
QuintilesIMS
Mallinckrodt
Covington
McKesson
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.